EWG Seeks Realistic FDA Review Deadlines In Sunscreen Innovation Act
This article was originally published in The Rose Sheet
While the Environmental Working Group supports the Sunscreen Innovation Act, it would like to see realistic deadlines put in place to accelerate FDA’s review of sunscreen-ingredient time-and-extent applications without including a default mechanism that would grant free market access to certain sunscreen actives when FDA fails to act within allotted timeframes.
You may also be interested in...
NGO reiterates concerns about FDA-approved sunscreen ingredients, spray formats and high-SPF products in its 2014 Sunscreen Guide, based on a review of more than 700 sun-protection products available to U.S. consumers. In tandem with this year’s report, EWG launches a Sun Safety campaign encouraging sunscreen use, one of the few components of its messaging with which the Personal Care Products Council agrees.
The longest-serving member of Congress says he is committed to working with members of both parties to approve the Sunscreen Innovation Act so it can be signed into law this year. The bill would impose tight deadlines on FDA’s review of TEA applications for sunscreen ingredients, eight of which are pending currently.
The Sunscreen Innovation Act, introduced in both the House and the Senate, would streamline the process for FDA review of sunscreen TEAs and impose deadlines for agency action.